Figure 3
Schematic representation, along with different stages of neurodevelopment, of emblematic (epi)genetic determinants of individual susceptibility/resistance to develop a stressed neuromatrix. 11βHSD2, 11β-Hydroxysteroid dehydrogenase type 2; CRF, corticotropin-releasing factor; GR, glucocorticoid receptor; H3K9Ac, H3 lysine 9 acetylation; HPC, hippocampus; PVN, paraventricular nucleus of the hypothalamus.
